Preview: Rockwell Medical's Earnings
Portfolio Pulse from Benzinga Insights
Rockwell Medical (NASDAQ:RMTI) is scheduled to release its quarterly earnings report on March 21, 2024. Analysts predict an EPS of $-0.07. The company's past performance shows a mixed reaction to earnings reports, with the last quarter resulting in a 12.76% share price increase following an EPS beat. Shares are currently trading at $1.41, up 17.39% over the last year. Investors are looking for positive guidance for the next quarter.
March 20, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rockwell Medical is anticipated to report a quarterly EPS of $-0.07 on March 21, 2024. The company's stock has shown sensitivity to earnings reports and guidance, with a significant increase after the last quarter's beat.
Given Rockwell Medical's history of stock price sensitivity to earnings reports and guidance, the upcoming earnings announcement is crucial. The positive trend in the stock price over the last year, coupled with the company's ability to beat the last quarter's EPS estimate, suggests a potential for a positive short-term impact on the stock price, especially if the company beats the EPS estimate again or provides optimistic future guidance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100